Skip to content
Surf Wiki
Save to docs
general/calcium-channel-blockers

From Surf Wiki (app.surf) — the open knowledge base

Isradipine

Antihypertensive drug of the calcium channel blocker class


Antihypertensive drug of the calcium channel blocker class

| Drugs.com = | elimination_half-life = 8 hours

Isradipine (tradenames DynaCirc, Prescal) is a calcium channel blocker of the dihydropyridine class. It is usually prescribed for the treatment of high blood pressure in order to reduce the risk of stroke and heart attack.

It was patented in 1978 and approved for medical use in 1989.

Medical uses

Isradipine is given as either a 2.5 mg or 5 mg capsule.

Side effects

Common side effects include:

  • Dizziness
  • Warmth, redness, or tingly feeling under your skin
  • Headache
  • Weakness, tired feeling
  • Nausea, vomiting, diarrhea, upset stomach
  • Skin rash or itching

Serious side effects include:

  • Lightheadedness or fainting
  • Shortness of breath, especially from minimal physical activity
  • Swelling in the hands and feet
  • Rapid and/or heavy heartbeat
  • Chest pain

Drug interactions

It is advised that those using isradipine not take dolasetron (Anzemet), as both agents can cause a dose-dependent PR interval and QRS complex prolongation.

Itraconazole (Onmel/Sporanox) exhibits a negative inotropic effect on the heart and thus could spur an additive effect when used concomitantly with isradipine. Itraconazole also inhibits an important cytochrome liver enzyme (CYP 450 3A4) which is needed to metabolize isradipine and other calcium channel blockers. This will increase plasma levels of isradipine and could cause an unintentional overdose of the medication. Caution is advised when administering both agents together.

Tizanidine demonstrates anti-hypertensive effects and should be avoided in patients taking isradipine due to the possibility of synergism between both medications.

The antibiotic rifampin lowered plasma concentrations of isradipine to below detectable limits.

Cimetidine increased isradipine mean peak plasma levels. A downward dose adjustment may be necessary with this particular instance of polypharmacy.

Severe hypotension was reported with fentanyl anesthesia when it was combined with other calcium channel blockers. Even though isradipine, another calcium channel blocker, has not been used in conjunction with fentanyl anesthesia in any studies, caution is advised.

Overdose

Symptoms of an isradipine overdose include:

  • Lethargy
  • Sinus tachycardia
  • Transient hypotension

Stereochemistry

Isradipine contains a stereocenter and consists of two enantiomers, more precisely atropisomers. This is a racemate, i.e. a 1: 1 mixture of (R)- and the (S)-forms:

Enantiomers of Isradipine
[[File:(R)-Isradipin Structural Formula V1.svg200 px]]
CAS-Nummer: 84260-63-9

References

References

  1. (2006). "Analogue-based Drug Discovery". John Wiley & Sons.
  2. "Isradipine Side Effects".
  3. "Isradipine and Anzemet Drug Interactions".
  4. "Isradipine and Onmel Drug Interactions".
  5. "Isradipine and Zanaflex Drug Interactions".
  6. "Isradipine: Brands, Medical Use, Clinical Data".
  7. Rote Liste Service GmbH (Hrsg.): ''Rote Liste 2017 – Arzneimittelverzeichnis für Deutschland (einschließlich EU-Zulassungen und bestimmter Medizinprodukte)''. Rote Liste Service GmbH, Frankfurt/Main, 2017, Aufl. 57, {{ISBN. 978-3-946057-10-9, S. 193.
Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

Want to explore this topic further?

Ask Mako anything about Isradipine — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report